TransMedics Group (TMDX)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of TransMedics Group (TMDX)
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Key Insights
Critical company metrics and information
Share Price
$69.84Market Cap
$2.34 BillionTotal Outstanding Shares
33.56 Million SharesTotal Employees
584Dividend
No dividendIPO Date
May 2, 2019SIC Description
Electromedical & Electrotherapeutic ApparatusHomepage
https://www.transmedics.com
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities, Continuing | $22.61 Million |
| Net Cash Flow | $-97.02 Million |
| Net Cash Flow From Operating Activities | $37.44 Million |
| Net Cash Flow From Investing Activities | $-157.51 Million |
| Net Cash Flow From Operating Activities, Continuing | $37.44 Million |
| Exchange Gains/Losses | $443,000.00 |
| Net Cash Flow, Continuing | $-97.46 Million |
| Net Cash Flow From Investing Activities, Continuing | $-157.51 Million |
| Net Cash Flow From Financing Activities | $22.61 Million |
Income Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Basic Earnings Per Share | $0.99 |
| Net Income/Loss Attributable To Parent | $32.64 Million |
| Income/Loss From Continuing Operations After Tax | $31.16 Million |
| Basic Average Shares | $66.42 Million |
| Gross Profit | $237.99 Million |
| Research and Development | $50.27 Million |
| Operating Income/Loss | $31.45 Million |
| Diluted Earnings Per Share | $0.94 |
| Net Income/Loss Available To Common Stockholders, Basic | $32.64 Million |
| Revenues | $401.09 Million |
| Nonoperating Income/Loss | $1.20 Million |
| Benefits Costs and Expenses | $368.44 Million |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Income/Loss From Continuing Operations Before Tax | $32.65 Million |
| Selling, General, and Administrative Expenses | $156.27 Million |
| Operating Expenses | $206.54 Million |
| Diluted Average Shares | $70.71 Million |
| Costs And Expenses | $368.44 Million |
| Income Tax Expense/Benefit | $1.50 Million |
| Cost Of Revenue | $163.10 Million |
| Income Tax Expense/Benefit, Current | $16,000.00 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Net Income/Loss | $32.64 Million |
Balance Sheet
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Assets | $785.57 Million |
| Noncurrent Assets | $293.10 Million |
| Current Assets | $492.48 Million |
| Intangible Assets | $2.20 Million |
| Fixed Assets | $271.74 Million |
| Other Non-current Assets | $19.16 Million |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Wages | $20.77 Million |
| Liabilities And Equity | $785.57 Million |
| Equity Attributable To Parent | $209.92 Million |
| Inventory | $52.15 Million |
| Noncurrent Liabilities | $515.60 Million |
| Other Current Assets | $440.32 Million |
| Current Liabilities | $60.05 Million |
| Liabilities | $575.65 Million |
| Other Current Liabilities | $26.15 Million |
| Equity | $209.92 Million |
| Accounts Payable | $13.13 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.